BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9763574)

  • 21. Clonal analysis of myelodysplastic syndrome: monosomy 7 is expressed in the myeloid lineage, but not in the lymphoid lineage as detected by fluorescent in situ hybridization.
    Gerritsen WR; Donohue J; Bauman J; Jhanwar SC; Kernan NA; Castro-Malaspina H; O'Reilly RJ; Bourhis JH
    Blood; 1992 Jul; 80(1):217-24. PubMed ID: 1611087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phenotypic and functional analysis of bone marrow progenitor cell compartment in bone marrow failure.
    Maciejewski JP; Anderson S; Katevas P; Young NS
    Br J Haematol; 1994 Jun; 87(2):227-34. PubMed ID: 7524621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fas/Apo-1 (CD95) expression and apoptosis in patients with myelodysplastic syndromes.
    Bouscary D; De Vos J; Guesnu M; Jondeau K; Viguier F; Melle J; Picard F; Dreyfus F; Fontenay-Roupie M
    Leukemia; 1997 Jun; 11(6):839-45. PubMed ID: 9177438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytogenetic clonality in myelodysplastic syndromes studied with fluorescence in situ hybridization: lineage, response to growth factor therapy, and clone expansion.
    Anastasi J; Feng J; Le Beau MM; Larson RA; Rowley JD; Vardiman JW
    Blood; 1993 Mar; 81(6):1580-5. PubMed ID: 8453104
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polyclonal primitive hematopoietic progenitors can be detected in mobilized peripheral blood from patients with high-risk myelodysplastic syndromes.
    Delforge M; Demuynck H; Vandenberghe P; Verhoef G; Zachée P; van Duppen V; Marijnen P; Van den Berghe H; Boogaerts MA
    Blood; 1995 Nov; 86(10):3660-7. PubMed ID: 7579331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perturbed hematopoietic stem and progenitor cell hierarchy in myelodysplastic syndromes patients with monosomy 7 as the sole cytogenetic abnormality.
    Dimitriou M; Woll PS; Mortera-Blanco T; Karimi M; Wedge DC; Doolittle H; Douagi I; Papaemmanuil E; Jacobsen SE; Hellström-Lindberg E
    Oncotarget; 2016 Nov; 7(45):72685-72698. PubMed ID: 27683035
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fas-mediated apoptosis is important in regulating cell replication and death in trisomy 8 hematopoietic cells but not in cells with other cytogenetic abnormalities.
    Sloand EM; Kim S; Fuhrer M; Risitano AM; Nakamura R; Maciejewski JP; Barrett AJ; Young NS
    Blood; 2002 Dec; 100(13):4427-32. PubMed ID: 12393649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dyspoietic changes associated with hepatosplenic T-cell lymphoma are not a manifestation of a myelodysplastic syndrome: analysis of 25 patients.
    Yabe M; Medeiros LJ; Tang G; Wang SA; P Patel K; Routbort M; Bhagat G; Bueso-Ramos CE; Jorgensen JL; Luthra R; Chen W; Muzzafar T; Kanagal-Shamanna R; Khoury JD; Daneshbod Y; Davanlou M; Li S; Young KH; Miranda RN
    Hum Pathol; 2016 Apr; 50():109-17. PubMed ID: 26997444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clonal CD5-positive B lymphocytes in myelodysplastic syndrome with systemic vasculitis and trisomy 8.
    Billström R; Johansson B; Strömbeck B; el-Rifai W; Larramendy M; Olofsson T; Mitelman F; Knuutila S
    Ann Hematol; 1997 Jan; 74(1):37-40. PubMed ID: 9031614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The immunophenotype of different immature, myeloid and B-cell lineage-committed CD34+ hematopoietic cells allows discrimination between normal/reactive and myelodysplastic syndrome precursors.
    Matarraz S; López A; Barrena S; Fernandez C; Jensen E; Flores J; Bárcena P; Rasillo A; Sayagues JM; Sánchez ML; Hernandez-Campo P; Hernandez Rivas JM; Salvador C; Fernandez-Mosteirín N; Giralt M; Perdiguer L; Orfao A
    Leukemia; 2008 Jun; 22(6):1175-83. PubMed ID: 18337765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Flow cytometric detection of accelerated telomere shortening in myelodysplastic syndromes: correlations with aetiological and clinical-biological findings.
    Rigolin GM; Porta MD; Bugli AM; Castagnari B; Mauro E; Bragotti LZ; Ciccone M; Cuneo A; Castoldi G
    Eur J Haematol; 2004 Nov; 73(5):351-8. PubMed ID: 15458514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of trisomy 12 in CD34+ progenitor cells in a patient with B-cell chronic lymphocytic leukemia by fluorescence in situ hybridization.
    Gahn B; Schäfer C; Neef J; Troff C; Feuring-Buske M; Hiddemann W; Wörmann B
    Ann Oncol; 1997; 8 Suppl 2():55-7. PubMed ID: 9209642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immature CD34+CD19- progenitor/stem cells in TEL/AML1-positive acute lymphoblastic leukemia are genetically and functionally normal.
    Hotfilder M; Röttgers S; Rosemann A; Jürgens H; Harbott J; Vormoor J
    Blood; 2002 Jul; 100(2):640-6. PubMed ID: 12091359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of trisomy 8 by fluorescence in situ hybridization on bone marrow smears from patients with subtle myelodysplastic changes.
    Brynes RK; Swayne D; McCourty A; Dosik GM; Traweek ST; Slovak ML
    Arch Pathol Lab Med; 1994 Dec; 118(12):1196-200. PubMed ID: 7979913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolation and characterization of hematopoietic progenitor/stem cells in 5q-deleted myelodysplastic syndromes: evidence for involvement at the hematopoietic stem cell level.
    Nilsson L; Astrand-Grundström I; Arvidsson I; Jacobsson B; Hellström-Lindberg E; Hast R; Jacobsen SE
    Blood; 2000 Sep; 96(6):2012-21. PubMed ID: 10979941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distinctive gene expression profiles of CD34 cells from patients with myelodysplastic syndrome characterized by specific chromosomal abnormalities.
    Chen G; Zeng W; Miyazato A; Billings E; Maciejewski JP; Kajigaya S; Sloand EM; Young NS
    Blood; 2004 Dec; 104(13):4210-8. PubMed ID: 15315976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blast colony-forming cells in myelodysplastic syndrome: decreased potential to generate erythroid precursors.
    Backx B; Broeders L; Touw I; Löwenberg B
    Leukemia; 1993 Jan; 7(1):75-9. PubMed ID: 8418382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional and phenotypic characterization of cord blood and bone marrow subsets expressing FLT3 (CD135) receptor tyrosine kinase.
    Rappold I; Ziegler BL; Köhler I; Marchetto S; Rosnet O; Birnbaum D; Simmons PJ; Zannettino AC; Hill B; Neu S; Knapp W; Alitalo R; Alitalo K; Ullrich A; Kanz L; Bühring HJ
    Blood; 1997 Jul; 90(1):111-25. PubMed ID: 9207445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of cytokines in leukemic type growth of myelodysplastic CD34+ cells.
    Sawada K; Ieko M; Notoya A; Tarumi T; Koizumi K; Kitayama S; Nishio H; Fukada Y; Yasukouchi T; Yamaguchi M; Katoh S; Koike T
    Blood; 1996 Jul; 88(1):319-27. PubMed ID: 8704190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The generation of human natural killer cells from CD34+/DR- primitive progenitors in long-term bone marrow culture.
    Miller JS; Verfaillie C; McGlave P
    Blood; 1992 Nov; 80(9):2182-7. PubMed ID: 1384796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.